>
Biohit´s innovations prevent illnesses and improve quality of life

Innovating for health

Biohit is a Finnish biotechnology company specialising in the development, manufacture and marketing of products and solutions for the early diagnosis and prevention of gastrointestinal and chronic diseases.

We specialize in digestive disease diagnostics, offering a portfolio of unique and patented tests designed to transform clinical practice by making screening, diagnosis and monitoring of gastrointestinal diseases more efficient and cost effective. To learn further on our impact on healthcare and society, please see here.

Our comprehensive diagnostic test range

Our diagnostic prowess extends across a comprehensive range of tests, encompassing both Point-of-Care and laboratory-based solutions. For detailed information about our diagnostic offerings, please see here.

Introducing Acetium®: A breakthrough in gastrointestinal health and smoking cessation

We also have our own unique, patented range of Acetium® products for gastrointestinal health and smoking cessation. Acetium is a Medical Device (EU classification) and is available in pharmacies and supermarkets here.

News

01.07.2023

Constitutive Meeting of Biohit Oyj’s Board of Directors

Read more
14.06.2023

Decisions of the Annual General Meeting of Biohit Oyj

Read more
24.05.2023

Notice of Biohit Oyj’s Annual General Meeting 2023

Read more

Events

27.11.2023

Finnish Medical Convention, Helsinki, Finland 24.-26. January 2024

Read more
27.11.2023

Medlab Middle East, Dubai, UAE 5.-8. February 2024

Read more
25.10.2023

Internist Days, Helsinki 16.-17. November 2023

Read more

Product catalogue

Interested?

"*" indicates required fields

Name*
Email*